Novavax Gains US FDA Advisory Committee Endorsement, But So Does Myocarditis Risk Statement

 
• By Derrick Gingery
  
FDA vaccines advisory committee meeting screenshot
The Vaccines and Related Biological Products Advisory Committee vote on the Novavax COVID-19 vaccine is announced during the 7 June meeting. • Source: screenshot
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers